IOM Pushes For FDA Collaboration With Foreign Regulators
This article was originally published in The Tan Sheet
Executive Summary
In a report on how FDA, industry and other stakeholders can strengthen food and drug regulatory systems abroad, the Institute of Medicine recommends the agency provide incentives for foreign regulators to meet U.S. standards and facilitate training and for the government to help hold importers liable.
You may also be interested in...
Public/Private Cooperation, Tailored Assistance Deemed Key To Enhancing Quality Of US Drug Imports
Public health experts tell committee that much work lies ahead in strengthening the regulatory systems of low-and middle-income countries, and recommend ways to bolster these systems and improve the quality of imports.
FDA Global Panel Focuses On Developing Countries’ Reg Systems
An FDA Science Board subcommittee will assess safety awareness in countries exporting food and medical products to the U.S., and identifies promising approaches to strengthening regulatory systems in those countries, says Chairman Jeff Bender.
FDA Global Panel Focuses On Developing Countries’ Reg Systems
An FDA Science Board subcommittee will assess safety awareness in countries exporting food and medical products to the U.S., and identifies promising approaches to strengthening regulatory systems in those countries, says Chairman Jeff Bender.